Cargando…
Antitussive effects of the peripherally restricted GABA(B) receptor agonist lesogaberan in guinea pigs: comparison to baclofen and other GABA(B) receptor-selective agonists
BACKGROUND: Gastroesophageal reflux disease (GERD) is a common cause of chronic cough. Both acid and nonacid reflux is thought to play a role in the initiation of coughing and cough hypersensitivity. The GABA(B) receptor agonist lesogaberan was developed as a peripherally restricted anti-reflux ther...
Autores principales: | Canning, Brendan J, Mori, Nanako, Lehmann, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520872/ https://www.ncbi.nlm.nih.gov/pubmed/23025757 http://dx.doi.org/10.1186/1745-9974-8-7 |
Ejemplares similares
-
Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis
por: Bhattacharya, Dipankar, et al.
Publicado: (2021) -
GABA(B)-Agonistic Activity of Certain Baclofen Homologues
por: Attia, Mohamed I., et al.
Publicado: (2013) -
Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects: A Novel GABA(B)-Receptor Agonist Reflux Inhibitor
por: Niazi, Mohammad, et al.
Publicado: (2012) -
GABA(B)
receptor agonist baclofen promotes central nervous system remyelination
por: Serrano‐Regal, Mari Paz, et al.
Publicado: (2022) -
Influence of GABA-B Agonist Baclofen on Capsaicin-Induced Excitation of Secondary Peristalsis in Humans
por: Lei, Wei-Yi, et al.
Publicado: (2017)